Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients

Human Molecular Genetics

Volumn 20, Issue 18, 2011, Pages 3642-3652

  Mitne Neto, Miguel ^a,b   Machado Costa, Marcela ^c   Marchetto, Maria C N ^d   Bengtson, Mario H ^e   Joazeiro, Claudio A ^e   Tsuda, Hiroshi ^f   Bellen, Hugo J ^f   Silva, Helga C A ^c   Oliveira, Acary S B ^c   Lazar, Monize ^b   Muotri, Alysson R ^a   Zatz, Mayana ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; VAMP ASSOCIATED PROTEIN B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MOTONEURON; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIBLING;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MOTOR NEURONS; MUTATION; PEDIGREE; VESICULAR TRANSPORT PROTEINS;

ANIMALIA;

EID: 80052225992     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr284     Document Type: Article

References (55)

1. Goodall, E.F. and Morrison, K.E. (2006) Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert. Rev. Mol. Med., 8, 1-22.
2. Rowland, L.P. and Shneider, N.A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med., 344, 1688-1700.
3. Beleza-Meireles, A. and Al-Chalabi, A. (2009) Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph. Lateral Scler., 10, 1-14.
4. Pasinelli, P. and Brown, R.H. (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neuron., 7, 710-723.
5. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
6. Gitcho, M.A., Baloh, R.H., Chakraverty, S., Mayo, K., Norton, J.B., Levitch, D., Hatanpaa, K.J., White, C.L. 3rd, Bigio, E.H., Caselli, R. et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol., 63, 535-538.
7. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E. et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 319, 1668-1672.
8. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F. et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet., 40, 572-574.
9. Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P. et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323, 1208-1211.
10. Kwiatkowski, T.J. Jr, Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T. et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323, 1205-1208.
11. Nishimura, A.L., Mitne-Neto, M., Silva, H.A.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J., Skehel, P. and Zatz, M. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 75, 822-831.
12. Nishimura, A.L., Mitne-Neto, M., Silva, H.C.A., Oliveira, J.R.M., Vainzof, M. and Zatz, M. (2004) A novel locus for a late onset amyotrophic lateral sclrerosis/motor neuron disease (ALS/MND) variant at 20q13. J. Med. Genet., 41, 315-320.
13. Nishimura, A.L., Al-Chalabi, A. and Zatz, M. (2007) A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet., 118, 499-500.
14. Funke, A.D., Esser, M., Krüttgen, A., Weis, J., Mitne-Neto, M., Lazar, M., Nishimura, A.L., Sperfeld, A.D., Trillenberg, P., Senderek, J. et al. (2010) The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin. Genet., 77, 302-303.
15. Millecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noël, L., Russaouen, O., Bruneteau, G., Pradat, P.F. et al. (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J. Med. Genet., 47, 554-560.
16. Chen, H.J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G. and de Belleroche, J.S. (2010) Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem., 285, 40266-40281.
17. Hirano, M. (2008) VAPB: new genetic clues to the pathogenesis of ALS. Neurology, 70, 1161-1162.
18. Landers, J.E., Leclerc, A.L., Shi, L., Virkud, A., Cho, T., Maxwell, M.M., Henry, A.F., Polak, M., Glass, J.D., Kwiatkowski, T.J. et al. (2008) New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology, 70, 1179-1185.
19. Weir, M.L., Klip, A. and Trimble, W.S. (1998) Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem. J., 333, 247-251.
20. Nishimura, Y., Hayashi, M., Inada, H. and Tanaka, T. (1999) Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun., 254, 21-26.
21. Ratnaparkhi, A., Lawless, G.M., Schweizer, F.E., Golshani, P. and Jackson, G.R. (2008) A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE, 3, e2334.
22. Kaiser, S.E., Brickner, J.H., Reilein, A.R., Fenn, T.D., Walter, P. and Brunger, A.T. (2005) Structural basis of FFAT motif-mediated ER targeting. Structure, 13, 1035-1045.
23. Skehel, P., Fabian-Fine, R. and Kandel, E. (2000) Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl Acad. Sci. USA, 97, 1101-1106.
24. Lev, S., Halevy, D.B., Peretti, D. and Dahan, N. (2008) The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol., 18, 282-290.
25. Tsuda, H., Han, S.M., Yang, Y., Tong, C., Lin, Y.Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J., Miller, M.A. and Bellen, H.J. (2008) The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell, 133, 963-977.
26. Mitne-Neto, M., Ramos, C.R., Pimenta, D.C., Luz, J.S., Nishimura, A.L., Gonzales, F.A., Oliveira, C.C. and Zatz, M. (2007) A mutation in human VAP-B-MSP domain, present in ALS patients, affects the interaction with other cellular proteins. Protein Expr. Purif., 55, 139-146.
27. Gkogkas, C., Middleton, S., Kremer, A.M., Wardrope, C., Hannah, M., Gillingwater, T.H. and Skehel, P. (2008) VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet., 17, 1517-1526.
28. Wang, L., Popko, B. and Roos, R.P. (2011) The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet., 20, 1008-1015.
29. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., Jaarsma, D. and Hoogenraad, C.C. (2007) Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci., 27, 9801-9815.
30. Anagnostou, G., Akbar, M.T., Paul, P., Angelinetta, C., Steiner, T.J. and de Belleroche, J. (2010) Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging, 31, 969-985.
31. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 13, 861-872.
32. Marchetto, M.C., Carromeu, C., Acab, A., Yu, D., Yeo, G.W., Mu, Y., Chen, G., Gage, F.H. and Muotri, A.R. (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143, 527-539.
33. Marchetto, M.C., Muotri, A.R., Mu, Y., Smith, A.M., Cezar, G.G. and Gage, F.H. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell, 3, 649-657.
34. Kanekura, K., Nishimoto, I., Aiso, S. and Matsuoka, M. (2006) Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem., 28, 30223-30232.
35. Prosser, D.C., Tran, D., Gougeon, P.Y., Verly, C. and Ngsee, J.K. (2008) FFAT rescues APA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation. J. Cell Sci., 12, 3052-3061.
36. Suzuki, H., Kanekura, K., Levine, T.P., Kohno, K., Olkkonen, V.M., Aiso, S. and Matsuoka, M. (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem., 108, 973-985.
37. Fasana, E., Fossati, M., Ruggiano, A., Brambillasca, S., Hoogenraad, C.C., Navone, F., Francolini, M. and Borgese, N. (2010) A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB, 24, 1419-1430.
38. Kim, S., Leal, S., Halevy, D.B., Gomes, M. and Lev, S. (2010) Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated. J. Biol. Chem., 285, 13839-13849.
39. Chai, A., Withers, J., Koh, Y.H., Parry, K., Bao, H., Zhang, B., Budnik, V. and Pennetta, G. (2008) hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol. Genet., 17, 266-280.
40. Tudor, E.L., Galtrey, C.M., Perkinton, M.S., Lau, K.F., De Vos, K.J., Mitchell, J.C., Ackerley, S., Hortobágyi, T., Vámos, E., Leigh, P.N. et al. (2010) Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein- associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience, 167, 774-785.
41. Joazeiro, C.A.P., Anderson, K.C. and Hunter, T. (2006) Proteasome inhibitor drugs on the rise. Cancer Res., 16, 7840-7842.
42. Ludolph, A.C., Bendotti, C., Blaugrund, E., Chio, A., Greensmith, L., Loeffler, J.P., Mead, R., Niessen, H.G., Petri, S., Pradat, P.F. et al. (2010) Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph. Lateral Scler., 11, 38-45.
43. Pizzasegola, C., Caron, I., Daleno, C., Ronchi, A., Minoia, C., Carrì, M.T. and Bendotti, C. (2009) Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph. Lateral Scler., 10, 221-228.
44. Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price, D.L. and Cleveland, D.W. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327-338.
45. Bergemalm, D., Forsberg, K., Srivastava, V., Graffmo, K.S., Andersen, P.M., Brännström, T., Wingsle, G. and Marklund, S.L. (2010) Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. J. Neurochem., 114, 408-418.
46. Lagier-Tourenne, C. and Cleveland, D.W. (2009) Rethinking ALS: the FUS about TDP-43. Cell, 136, 1001-1004.
47. Wegorzewska, I., Bell, S., Cairns, N.J., Miller, T.M. and Baloh, R.H. (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA, 106, 18809-18814.
48. Ebert, A.D., Yu, J., Rose, F.F. Jr, Mattis, V.B., Lorson, C.L., Thomson, J.A. and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
49. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R. et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221.
50. Pennetta, G., Hiesinger, P.R., Fabian-Fine, R., Meinertzhagen, I.A. and Bellen, H.J. (2002) Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron, 35, 291-306.
51. Shi, J., Lua, S., Tong, J.S. and Song, J. (2010) Elimination of the native structure and solubility of the hVAPB MSP domain by the Pro56Ser mutation that causes amyotrophic lateral sclerosis. Biochemistry, 49, 3887-3897.
52. Furuita, K., Jee, J., Fukada, H., Mishima, M. and Kojima, C. (2010) Electrostatic interaction between oxysterol-binding protein and VAMP-associated protein A revealed by NMR and mutagenesis studies. J. Biol. Chem., 285, 12961-12970.
53. Gkogkas, C., Wardrope, C., Hannah, M. and Skehel, P. (2011) The ALS8-associated mutant VAPB(P56S) is resistant to proteolysis in neurons. J. Neurochem. doi: 10.1111/j.1471-4159.2011.07201.
54. Marchetto, M.C.N., Winner, B. and Gage, F.H. (2010) Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum. Mol. Genet., 19, R71-R76.
55. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. and Daley, G.Q. (2008) Disease-specific induced pluripotent stem (iPS) cells. Cell, 134, 877-886.